<DOC>
	<DOCNO>NCT00000438</DOCNO>
	<brief_summary>This study evaluate effectiveness medication naltrexone ( Revia ) treat alcoholism . Individuals inpatient 2 week period provide assessment alcohol withdrawal symptom , crave , mood . Following hospital discharge , individual assign randomly receive naltrexone daily , naltrexone twice day placebo . This part study last 12 week , regular measurement drink level , crave mood . Assessments conduct 6 12 month begin study .</brief_summary>
	<brief_title>Naltrexone Treatment Alcoholism</brief_title>
	<detailed_description />
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Meets criteria alcohol dependence . Committed alcohol abstinence treatment goal . Individuals require identify two family member close friend knowledgeable location , drink behavior , psychosocial status . Meets criteria psychoactive substance use disorder ( exclude nicotine caffeine ) . Meets criteria major psychiatric disorder need currently undergo pharmacotherapy . Females pregnant , lactating , use reliable method contraception . Currently experience serious medical condition would place risk interfere study participation . Experiencing acute hepatitis liver failure whose liver function test 3 time normal . Have history severe allergy , multiple adverse drug reaction know allergy naltrexone . Vocabulary 5th grade read level . Abnormal MRI scan . HIV infection due neurological sequela . Significant central nervous system disease . Seizure disorder history close head trauma . Neuroendocrine disorder . Treatment opiates within last six month .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>